Protective Actions of Anserine Under Diabetic Conditions

about

Protective Actions of Anserine Under Diabetic Conditions

Item

http://www.wikidata.org/entity/Q58742423

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Protective Actions of Anserine Under Diabetic Conditions

@en

Protective Actions of Anserine Under Diabetic Conditions

@nl

type

Item

label

Protective Actions of Anserine Under Diabetic Conditions

@en

Protective Actions of Anserine Under Diabetic Conditions

@nl

prefLabel

Protective Actions of Anserine Under Diabetic Conditions

@en

Protective Actions of Anserine Under Diabetic Conditions

@nl

P1476

Protective Actions of Anserine Under Diabetic Conditions

@en

P2093

Angela Trovato

http://www.w3.org/2001/XMLSchema#string

Christian Thiel

http://www.w3.org/2001/XMLSchema#string

Claus Peter Schmitt

http://www.w3.org/2001/XMLSchema#string

Elisabete Forsberg

http://www.w3.org/2001/XMLSchema#string

Maria Scuto

http://www.w3.org/2001/XMLSchema#string

Nadine Volk

http://www.w3.org/2001/XMLSchema#string

Sergio Modafferi

http://www.w3.org/2001/XMLSchema#string

Thomas Fleming

http://www.w3.org/2001/XMLSchema#string

Tim Weigand

http://www.w3.org/2001/XMLSchema#string

Verena Peters

http://www.w3.org/2001/XMLSchema#string

P2860

Physiology and pathophysiology of carnosine.

Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications

Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase

Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese.

The CNDP1 (CTG)5 Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes Duration

Molecular chaperones in the kidney: distribution, putative roles, and regulation.

A re-evaluation of the antioxidant activity of purified carnosine.

Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.

A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.

L-carnosine, a substrate of carnosinase-1, influences glucose metabolism.

P304

2751

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS19092751

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hans Baelde

P577

2018-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30217069

http://www.w3.org/2001/XMLSchema#string

P921

molecular biology

catalysis

P932

6164239

http://www.w3.org/2001/XMLSchema#string